| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 62.797 | 61.404 | 66.694 | 93.025 | 59.164 | 69.035 | 83.705 | 10.509 | 0 | 164.711 |
| Total Income - EUR | 62.797 | 61.516 | 66.694 | 93.235 | 59.575 | 69.237 | 83.708 | 10.682 | 49 | 164.715 |
| Total Expenses - EUR | 30.963 | 29.717 | 33.383 | 54.264 | 36.189 | 16.948 | 17.187 | 19.105 | 15.039 | 110.969 |
| Gross Profit/Loss - EUR | 31.834 | 31.799 | 33.311 | 38.970 | 23.386 | 52.289 | 66.520 | -8.423 | -14.990 | 53.747 |
| Net Profit/Loss - EUR | 29.951 | 31.184 | 31.755 | 38.070 | 22.789 | 51.648 | 65.226 | -8.529 | -14.990 | 44.600 |
| Employees | 4 | 4 | 3 | 5 | 3 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Argovamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.719 | 5.740 | 3.714 | 5.130 | 2.962 | 1.740 | 16.203 | 12.439 | 8.408 | 26.720 |
| Current Assets | 30.067 | 30.951 | 32.800 | 47.186 | 28.302 | 55.903 | 64.167 | 46.242 | 8.681 | 12.116 |
| Inventories | 0 | 0 | 22 | 41 | 145 | 39 | 38 | 38 | 38 | 38 |
| Receivables | 7.266 | 7.396 | 6.561 | 27.057 | 6.372 | 4.547 | 3.825 | 3.869 | 5.582 | 5.831 |
| Cash | 22.801 | 23.555 | 26.217 | 20.089 | 21.785 | 51.316 | 60.303 | 42.334 | 3.062 | 6.246 |
| Shareholders Funds | 30.004 | 31.237 | 31.808 | 38.122 | 22.839 | 51.698 | 65.275 | -8.480 | -23.444 | 21.287 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.011 | 13.816 | 11.230 | 18.470 | 11.428 | 7.542 | 15.711 | 67.722 | 40.964 | 18.416 |
| Income in Advance | 0 | 0 | 0 | 629 | 205 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Argovamed Srl